COMPLETED

Evaluating Home Testing Devices for the Management of Glaucoma

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

With the advancement in technology we have the opportunity of performing the glaucoma testing at home to monitor the disease. The purpose of this study is evaluating the feasibility and patient acceptance of home testing with head mounted perimetry; detection of progression with head mounted perimetry vs office based perimetry; and monitoring the eye pressure measured by patients at home using a portable tonometer.

Official Title

Evaluating Effectiveness of Home Testing Devises for Assisting in Management of Glaucoma Outside a Clinical Setting During a 2 Year Period.

Quick Facts

Study Start:2022-04-15
Study Completion:2025-02-17
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT05325996

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:20 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age 20-80 years
  2. 2. Mild and Moderate Open Angle Glaucoma (OAG)
  3. 3. Refraction under 12.00 diopter of spherical refractive error and astigmatism of less than 2.5 diopter.
  1. 1. Spherical refraction outside \> ± 12.00 D and cylinder correction \> +2.5 D.
  2. 2. Visual acuity worse than 20/50 either eye
  3. 3. Cataract surgery with or without Minimally Invasive Glaucoma Surgery (MIGS) less than 90 days prior to enrollment
  4. 4. Filtering surgeries less than 6 months prior to enrollment
  5. 5. Intraocular surgery other than:
  6. 1. Non-complicated MIGS more than 90 days prior to enrollment;
  7. 2. Cataract or refractive surgery performed more than 90 days before enrollment and without posterior capsule opacification
  8. 3. Other glaucoma surgery more than 6 months prior to enrollment.
  9. 6. History of systemic or ocular condition (other than glaucoma or mild to moderate cataract) known to affect visual function.
  10. 7. History of medication known to affect visual function or influence patient reaction time
  11. 8. Inability to use device after remote training session
  12. 9. Subjects unwilling and/or unable to participate

Contacts and Locations

Principal Investigator

M. Reza Razeghinejad, MD
PRINCIPAL_INVESTIGATOR
Wills Eye Hospital

Study Locations (Sites)

Wills Eye Hospital
Philadelphia, Pennsylvania, 19107
United States

Collaborators and Investigators

Sponsor: Wills Eye

  • M. Reza Razeghinejad, MD, PRINCIPAL_INVESTIGATOR, Wills Eye Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-04-15
Study Completion Date2025-02-17

Study Record Updates

Study Start Date2022-04-15
Study Completion Date2025-02-17

Terms related to this study

Keywords Provided by Researchers

  • Open Angle Glaucoma
  • Perimetery
  • Tonometry
  • Eye Pressure
  • Visual Field
  • Home Test

Additional Relevant MeSH Terms

  • Glaucoma, Open-Angle